Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Korro Bio (KRRO) Other financing activities (2023)

Korro Bio (KRRO) has disclosed Other financing activities for 1 consecutive years, with $2.6 million as the latest value for Q4 2023.

  • For the quarter ending Q4 2023, Other financing activities changed N/A year-over-year to $2.6 million, compared with a TTM value of $2.6 million through Sep 2024, changed N/A, and an annual FY2023 reading of -$2000.0, up 95.45% over the prior year.
  • Other financing activities was $2.6 million for Q4 2023 at Korro Bio, up from -$2.4 million in the prior quarter.
  • Across five years, Other financing activities topped out at $2.6 million in Q4 2023 and bottomed at -$2.4 million in Q3 2023.